The YouTuber identifies Boston Scientific as a pure Tier 1 robotics company, building physical systems for medical applications. Their Ferropulse platform uses robotic ablation for cardiac arrhythmias, showcasing full-stack integration of hardware, software, and navigation. Analysts project 28% upside as hospitals adopt next-gen robotic systems, though the YouTuber notes this is infrastructure and slower-moving.
“Analysts see roughly 28% upside ahead for BSX. As hospitals accelerate adoption of nextgen robotic systems like Ferropulse, the value in tier 1 is steady.” — ▶ 10:00